vs
POTLATCHDELTIC CORP（PCH）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是POTLATCHDELTIC CORP的2.0倍（$622.0M vs $314.2M），Royalty Pharma plc净利率更高（34.4% vs 8.2%，领先26.2%），POTLATCHDELTIC CORP同比增速更快（23.1% vs 4.8%），过去两年POTLATCHDELTIC CORP的营收复合增速更高（11.1% vs 4.6%）
PotlatchDeltic是一家总部位于美国华盛顿州斯波坎的多元化林产品企业，业务覆盖林木培育、木材加工及相关林制品的生产与供应，在林业资源管理和产品研发领域拥有成熟的运营体系，为建筑、家居等多个下游行业提供优质原材料与产品解决方案。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
PCH vs RPRX — 直观对比
营收规模更大
RPRX
是对方的2.0倍
$314.2M
营收增速更快
PCH
高出18.4%
4.8%
净利率更高
RPRX
高出26.2%
8.2%
两年增速更快
PCH
近两年复合增速
4.6%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $314.2M | $622.0M |
| 净利润 | $25.9M | $214.2M |
| 毛利率 | 18.2% | — |
| 营业利润率 | 11.2% | 62.4% |
| 净利率 | 8.2% | 34.4% |
| 营收同比 | 23.1% | 4.8% |
| 净利润同比 | 682.5% | 2.9% |
| 每股收益（稀释后） | $0.33 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PCHRPRX
| Q4 25 | — | $622.0M | ||
| Q3 25 | $314.2M | $609.3M | ||
| Q2 25 | $275.0M | $578.7M | ||
| Q1 25 | $268.3M | $568.2M | ||
| Q4 24 | $258.1M | $593.6M | ||
| Q3 24 | $255.1M | $564.7M | ||
| Q2 24 | $320.7M | $537.3M | ||
| Q1 24 | $228.1M | $568.0M |
净利润PCHRPRX
| Q4 25 | — | $214.2M | ||
| Q3 25 | $25.9M | $288.2M | ||
| Q2 25 | $7.4M | $30.2M | ||
| Q1 25 | $25.8M | $238.3M | ||
| Q4 24 | $5.2M | $208.2M | ||
| Q3 24 | $3.3M | $544.0M | ||
| Q2 24 | $13.7M | $102.0M | ||
| Q1 24 | $-305.0K | $4.8M |
毛利率PCHRPRX
| Q4 25 | — | — | ||
| Q3 25 | 18.2% | — | ||
| Q2 25 | 13.0% | — | ||
| Q1 25 | 17.8% | — | ||
| Q4 24 | 13.4% | — | ||
| Q3 24 | 10.8% | — | ||
| Q2 24 | 11.9% | — | ||
| Q1 24 | 7.0% | — |
营业利润率PCHRPRX
| Q4 25 | — | 62.4% | ||
| Q3 25 | 11.2% | 70.1% | ||
| Q2 25 | 5.0% | 36.3% | ||
| Q1 25 | 10.3% | 94.0% | ||
| Q4 24 | 5.2% | 60.9% | ||
| Q3 24 | 2.8% | — | ||
| Q2 24 | 5.4% | 50.2% | ||
| Q1 24 | -2.1% | -13.0% |
净利率PCHRPRX
| Q4 25 | — | 34.4% | ||
| Q3 25 | 8.2% | 47.3% | ||
| Q2 25 | 2.7% | 5.2% | ||
| Q1 25 | 9.6% | 41.9% | ||
| Q4 24 | 2.0% | 35.1% | ||
| Q3 24 | 1.3% | 96.3% | ||
| Q2 24 | 4.3% | 19.0% | ||
| Q1 24 | -0.1% | 0.8% |
每股收益（稀释后）PCHRPRX
| Q4 25 | — | $0.49 | ||
| Q3 25 | $0.33 | $0.67 | ||
| Q2 25 | $0.09 | $0.07 | ||
| Q1 25 | $0.33 | $0.55 | ||
| Q4 24 | $0.07 | $0.46 | ||
| Q3 24 | $0.04 | $1.21 | ||
| Q2 24 | $0.17 | $0.23 | ||
| Q1 24 | $0.00 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $88.8M | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $1.9B | $9.7B |
| 总资产 | $3.2B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资PCHRPRX
| Q4 25 | — | $618.7M | ||
| Q3 25 | $88.8M | $938.9M | ||
| Q2 25 | $95.3M | $631.9M | ||
| Q1 25 | $147.5M | $1.1B | ||
| Q4 24 | $151.6M | $929.0M | ||
| Q3 24 | $161.1M | $950.1M | ||
| Q2 24 | $199.7M | $1.8B | ||
| Q1 24 | $180.2M | $843.0M |
总债务PCHRPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | $1.0B | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益PCHRPRX
| Q4 25 | — | $9.7B | ||
| Q3 25 | $1.9B | $9.6B | ||
| Q2 25 | $1.9B | $9.5B | ||
| Q1 25 | $2.0B | $9.8B | ||
| Q4 24 | $2.0B | $10.3B | ||
| Q3 24 | $2.1B | $10.3B | ||
| Q2 24 | $2.1B | $9.8B | ||
| Q1 24 | $2.2B | $9.9B |
总资产PCHRPRX
| Q4 25 | — | $19.6B | ||
| Q3 25 | $3.2B | $19.3B | ||
| Q2 25 | $3.2B | $18.3B | ||
| Q1 25 | $3.3B | $17.6B | ||
| Q4 24 | $3.3B | $18.2B | ||
| Q3 24 | $3.3B | $18.0B | ||
| Q2 24 | $3.4B | $17.7B | ||
| Q1 24 | $3.4B | $16.1B |
负债/权益比PCHRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | 0.51× | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $65.7M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $50.1M | — |
| 自由现金流率自由现金流/营收 | 15.9% | — |
| 资本支出强度资本支出/营收 | 4.9% | — |
| 现金转化率经营现金流/净利润 | 2.54× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $132.4M | — |
8季度趋势，按日历期对齐
经营现金流PCHRPRX
| Q4 25 | — | $827.1M | ||
| Q3 25 | $65.7M | $702.6M | ||
| Q2 25 | $41.0M | $364.0M | ||
| Q1 25 | $49.1M | $596.1M | ||
| Q4 24 | $45.4M | $742.5M | ||
| Q3 24 | $26.5M | $703.6M | ||
| Q2 24 | $100.6M | $658.2M | ||
| Q1 24 | $16.0M | $664.6M |
自由现金流PCHRPRX
| Q4 25 | — | — | ||
| Q3 25 | $50.1M | — | ||
| Q2 25 | $30.6M | — | ||
| Q1 25 | $26.3M | — | ||
| Q4 24 | $25.4M | — | ||
| Q3 24 | $-8.2M | — | ||
| Q2 24 | $72.4M | — | ||
| Q1 24 | $2.0M | — |
自由现金流率PCHRPRX
| Q4 25 | — | — | ||
| Q3 25 | 15.9% | — | ||
| Q2 25 | 11.1% | — | ||
| Q1 25 | 9.8% | — | ||
| Q4 24 | 9.9% | — | ||
| Q3 24 | -3.2% | — | ||
| Q2 24 | 22.6% | — | ||
| Q1 24 | 0.9% | — |
资本支出强度PCHRPRX
| Q4 25 | — | — | ||
| Q3 25 | 4.9% | — | ||
| Q2 25 | 3.8% | — | ||
| Q1 25 | 8.5% | — | ||
| Q4 24 | 7.7% | — | ||
| Q3 24 | 13.6% | — | ||
| Q2 24 | 8.8% | — | ||
| Q1 24 | 6.1% | — |
现金转化率PCHRPRX
| Q4 25 | — | 3.86× | ||
| Q3 25 | 2.54× | 2.44× | ||
| Q2 25 | 5.58× | 12.06× | ||
| Q1 25 | 1.90× | 2.50× | ||
| Q4 24 | 8.74× | 3.57× | ||
| Q3 24 | 7.99× | 1.29× | ||
| Q2 24 | 7.35× | 6.45× | ||
| Q1 24 | — | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PCH
| Lumber | $131.8M | 42% |
| Timberlands | $52.5M | 17% |
| Rural Real Estate | $51.3M | 16% |
| Residuals And Panels | $34.0M | 11% |
| Pulpwood | $16.7M | 5% |
| Development Real Estate | $14.6M | 5% |
| Other | $8.1M | 3% |
| Other Products | $5.2M | 2% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
